These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27224516)

  • 1. Connecting HIV-1 integration and transcription: a step toward new treatments.
    Lucic B; Lusic M
    FEBS Lett; 2016 Jul; 590(13):1927-39. PubMed ID: 27224516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multifaceted Contributions of Chromatin to HIV-1 Integration, Transcription, and Latency.
    De Crignis E; Mahmoudi T
    Int Rev Cell Mol Biol; 2017; 328():197-252. PubMed ID: 28069134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus (HIV)-1 integration sites in viral latency.
    Rezaei SD; Cameron PU
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):88-96. PubMed ID: 25573791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 gene therapy at pre-integration and provirus DNA levels.
    Nazari R; Joshi S
    Curr Gene Ther; 2009 Feb; 9(1):20-5. PubMed ID: 19275568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV type-1 latency: targeted induction of proviral reservoirs.
    Graci JD; Colacino JM; Peltz SW; Dougherty JP; Gu Z
    Antivir Chem Chemother; 2009; 19(5):177-87. PubMed ID: 19483266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of HIV integration and therapeutic intervention.
    Vandegraaff N; Engelman A
    Expert Rev Mol Med; 2007 Feb; 9(6):1-19. PubMed ID: 17320002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gene expression: lessons from provirus and non-integrated DNA.
    Wu Y
    Retrovirology; 2004 Jun; 1():13. PubMed ID: 15219234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive update.
    Hamid FB; Kim J; Shin CG
    AIDS Res Ther; 2017 Feb; 14(1):9. PubMed ID: 28209198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Latency Gets a New Histone Mark.
    Nikolai BC; Feng Q
    Cell Host Microbe; 2017 May; 21(5):549-550. PubMed ID: 28494231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children.
    Luzuriaga K
    Annu Rev Med; 2016; 67():201-13. PubMed ID: 26768239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review.
    Re MC; Vitone F; Bon I; Schiavone P; Gibellini D
    New Microbiol; 2006 Apr; 29(2):81-8. PubMed ID: 16841548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics for HIV-1 reactivation from latency.
    Sgarbanti M; Battistini A
    Curr Opin Virol; 2013 Aug; 3(4):394-401. PubMed ID: 23810462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal tethering and proviral integration.
    Delelis O; Zamborlini A; Thierry S; Saïb A
    Biochim Biophys Acta; 2010; 1799(3-4):207-16. PubMed ID: 19683084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of HIV-1 latency by chromatin structure and nuclear architecture.
    Lusic M; Giacca M
    J Mol Biol; 2015 Feb; 427(3):688-94. PubMed ID: 25073101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin.
    Sowd GA; Serrao E; Wang H; Wang W; Fadel HJ; Poeschla EM; Engelman AN
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):E1054-63. PubMed ID: 26858452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental approaches to the study of HIV-1 latency.
    Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
    Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.